BURST-AF TRIAL AT AF Symposium 2025

Today Dr. Ante Anic from KBC Split presented promising first-in-human preliminary results from the BURST-AF Trial during the AF Symposium Spotlight session.

In total, 78 subjects were enrolled across three European sites. All lesion sets were completed using the Coherent Sine-Burst Electroporation™ (CSE™) generator and CSE ablation catheter in either the circular, linear and/or focal configuration. Safety assessments included a brain MRI sub-study, microbubble observation during PFA application, PV stenosis, and esophageal injury. Seventy-seven of 78 subjects have undergone remapping at ~90 days.

Dr. Anic shared preliminary study results demonstrating an excellent safety profile combined with a high acute procedural efficacy and chronic durability at 90 days.